Empowered Funds’s Artiva Biotherapeutics ARTV Stock Holding History

Empowered Funds’s Portfolio ARTV Stock Details ARTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$245K	Buy	+34,420	New	+$347K	﹤0.01%	2135

Other funds holding ARTV

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Revelation Capital Management Sausalito, California $8.01M AUM 49.3% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Empowered Funds's ARTV Position: Q3 2026 in Review

Empowered Funds opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 34,420 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #2135 among its holdings.

57 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

Empowered Funds held 34,420 shares of Artiva Biotherapeutics worth $245K as of Q3 2026.
Artiva Biotherapeutics was a new Empowered Funds position in Q3 2026.
Artiva Biotherapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2135 holding.
57 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.